Julie Rubinstein
Known title: President and COOCIK: 0001780664
Associated companies
Transaction History
| ADPT | ▲ Buy | Option Exercise | 11,881 | $144K | 10/8/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 11,881 | $305K | 10/8/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 11,881 | $144K | 10/7/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 11,881 | $314K | 10/7/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 11,881 | $144K | 10/6/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 9,381 | $257K | 10/6/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 1,100 | $31K | 10/6/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 901 | $27K | 10/6/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 499 | $15K | 10/6/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 11,881 | $144K | 10/5/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 6,699 | $193K | 10/5/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 5,182 | $154K | 10/5/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 11,881 | $144K | 10/2/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 11,881 | $334K | 10/2/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 11,881 | $144K | 10/1/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 6,081 | $168K | 10/1/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 5,800 | $166K | 10/1/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,707 | $124K | 4/27/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,037 | $271K | 4/27/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $267K | 4/24/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $125K | 4/24/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $125K | 4/23/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $262K | 4/23/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $269K | 4/22/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $125K | 4/22/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 30,941 | $454K | 4/21/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 11,881 | $144K | 4/21/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $125K | 4/21/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $277K | 4/20/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $125K | 4/20/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $125K | 4/17/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $278K | 4/17/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $125K | 4/16/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $270K | 4/16/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $125K | 4/15/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $278K | 4/15/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $125K | 4/14/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $278K | 4/14/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 8,109 | $59K | 4/13/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 6,613 | $56K | 4/13/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 15,722 | $204K | 4/13/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 3,338 | $47K | 4/13/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $107K | 4/10/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 18,660 | $238K | 4/10/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 400 | $5K | 4/10/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 2,100 | $30K | 4/9/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $107K | 4/9/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 16,960 | $234K | 4/9/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 30,841 | $457K | 4/8/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 100 | $2K | 4/8/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 11,881 | $144K | 4/8/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $107K | 4/8/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $107K | 4/7/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $258K | 4/7/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $107K | 4/6/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $273K | 4/6/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $107K | 4/2/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $278K | 4/2/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $107K | 4/1/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $275K | 4/1/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $107K | 3/31/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $256K | 3/31/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $107K | 3/30/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $241K | 3/30/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 16,322 | $220K | 3/27/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $107K | 3/27/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 2,738 | $34K | 3/27/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $107K | 3/26/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $269K | 3/26/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $107K | 3/25/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $272K | 3/25/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $107K | 3/24/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $261K | 3/24/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $107K | 3/23/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $264K | 3/23/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 10,783 | $78K | 3/20/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $255K | 3/20/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 3,939 | $26K | 3/20/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $251K | 3/19/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $96K | 3/19/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $96K | 3/18/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $251K | 3/18/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $96K | 3/17/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $255K | 3/17/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $96K | 3/16/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $256K | 3/16/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $247K | 3/13/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $96K | 3/13/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 5,400 | $73K | 3/12/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $96K | 3/12/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 13,660 | $173K | 3/12/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 122,523 | $1.6M | 3/11/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $96K | 3/11/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,060 | $268K | 3/11/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $96K | 3/10/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 400 | $5K | 3/10/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,460 | $286K | 3/10/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $96K | 3/9/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 11,881 | $144K | 3/9/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 30,941 | $458K | 3/9/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $96K | 3/6/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 11,881 | $144K | 3/6/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 30,941 | $468K | 3/6/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $96K | 3/5/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 11,881 | $144K | 3/5/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 30,941 | $495K | 3/5/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $96K | 3/4/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 11,881 | $144K | 3/4/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 30,941 | $514K | 3/4/2026 | View on chart |
| ADPT | ▲ Buy | Grant | 81,250 | $0 | 3/4/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,722 | $96K | 3/3/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 11,881 | $144K | 3/3/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 24,423 | $378K | 3/3/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 6,518 | $106K | 3/3/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 40,044 | $280K | 3/5/2025 | View on chart |
| ADPT | ▼ Sell | Open Market | 19,461 | $136K | 3/5/2025 | View on chart |
| ADPT | ▲ Buy | Grant | 175,000 | $0 | 3/4/2025 | View on chart |
| ADPT | ▼ Sell | Open Market | 25,580 | $88K | 3/5/2024 | View on chart |
| ADPT | ▼ Sell | Open Market | 13,490 | $48K | 3/5/2024 | View on chart |
| ADPT | ▲ Buy | Grant | 175,000 | $0 | 3/4/2024 | View on chart |
| ADPT | ▲ Buy | Grant | 132,979 | $0 | 3/6/2023 | View on chart |
| ADPT | ▼ Sell | Open Market | 22,668 | $194K | 3/6/2023 | View on chart |
| ADPT | ▼ Sell | Open Market | 4,613 | $55K | 3/7/2022 | View on chart |
| ADPT | ▲ Buy | Grant | 185,338 | $0 | 3/4/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Adaptive Biotechnologies Fair Value Lifted on MRD Optimism
Adaptive Biotechnologies saw a modest increase in its fair value estimate driven by optimism regarding minimal residual disease (MRD) data. This development provides a fundamental reason for potential valuation adjustments, distinct from the technical indicators currently showing a negative divergence. The stock remains within its 52-week range, with analysts maintaining a higher average target price than the current market levels.
Adaptive Biotechnologies Fair Value Lifted on MRD Optimism. Adaptive Biotechnologies saw a modest increase in its fair value estimate driven by optimism regarding minimal residual disease (MRD) data. This development provides a fundamental reason for potential valuation adjustments, distinct from the technical indicators currently showing a negative divergence. The stock remains within its 52-week range, with analysts maintaining a higher average target price than the current market levels.